TABLE 3.
Recipient and donor characteristics of mate kidneys with and without DGF.
| Mate kidney A, with DGF (n = 111) | Mate kidney B, without DGF (n = 111) | p-value | |
|---|---|---|---|
| Recipient | |||
| Age (years) | 56.0 ± 13.2 (58.0) | 58.7 ± 12.0 (62.0) | 0.11 |
| Male | 75 (67.6%) | 56 (50.5%) | 0.01 |
| Race | |||
| White | 53 (47.7%) | 63 (56.8%) | 0.23 |
| Black | 16 (14.4%) | 14 (12.%) | |
| Hispanic | 21 (18.9%) | 15 (13.5%) | |
| American Indian/Alaska Native | 7 (6.3%) | 12 (10.8%) | |
| Other | 14 (12.6%) | 7 (6.3%) | |
| BMI (kg/m2) | 27.9 ± 5.4 (27.5) | 27.8 ± 5.6 (27.6) | 0.92 |
| Diabetes | 40 (36.0%) | 28 (25.2%) | 0.08 |
| Preemptive | 14 (12.6%) | 56 (50.5%) | <0.0001 |
| Length of dialysis | 3.4 ± 2.4 (3.0) | 3.4 ± 2.6 (3.1) | 0.94 |
| Re-transplant | 13 (11.7%) | 8 (7.2%) | 0.25 |
| Donor | |||
| Age (years) | 39.1 ± 15.4 (37.0) | — | |
| Male | 69 (62.2%) | — | |
| Height (cm) | 169.8 ± 12.5 (170.4) | — | |
| KDPI (%) | 49.1 ± 25.7 (49.0) | — | |
| High KDPI | 14 (12.6%) | — | |
| DCD | 32 (28.8%) | — | |
| AKI | 51 (46.0%) | — | |
| Allocation | |||
| Local | 54 (48.6%) | — | |
| Regional | 26 (23.4%) | ||
| National | 31 (27.9%) | ||
| Induction | |||
| Alemtuzumab | 66 (59.5%) | 62 (55.9%) | 0.27 |
| Basiliximab | 34 (30.6%) | 43 (38.7%) | |
| Thymoglobulin | 11 (9.9%) | 6 (5.4%) | |
| CIT (hours) | 20.4 ± 6.7 (20.5) | 19.8 ± 7.0 (21.0) | 0.48 |